| Authors: |
Lugogo NL; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan., Han JK; Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia., Peters AT; Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Lee SE; Division of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Kraft M; Department of Medicine, Icahn School of Medicine, Mount Sinai Health System, New York, New York., Margolis MK; Patient Centered Science, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Shenoy SF; Global Medical Affairs, Amgen, Thousand Oaks, California., Martin N; Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts; Cytel Inc, Waltham, Massachusetts., Chandarana S; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland. Electronic address: chris.ambrose@astrazeneca.com. |
